First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical ...

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...

If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin ...

JMU scientists studied insulin-producing cells in fruit flies, finding that secretion is influenced by gut hormones, ...

More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.